Akoya Biosciences Inc (AKYA)
7.60
-0.44 (-5.47%)
USD |
NASDAQ |
Mar 20, 16:00
7.60
0.00 (0.00%)
After-Hours: 18:47
Akoya Biosciences Total Assets (Quarterly): 176.03M for Dec. 31, 2022
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 176.03M |
| September 30, 2022 | 176.46M |
| June 30, 2022 | 184.26M |
| March 31, 2022 | 187.13M |
| December 31, 2021 | 190.91M |
| Date | Value |
|---|---|
| September 30, 2021 | 195.41M |
| June 30, 2021 | 206.34M |
| March 31, 2021 | 74.48M |
| December 31, 2020 | 77.66M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
74.48M
Minimum
Mar 2021
206.34M
Maximum
Jun 2021
163.19M
Average
184.26M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| Agilent Technologies Inc | 10.92B |
| Bruker Corp | 3.612B |
| Azenta Inc | 3.292B |
| Harvard Bioscience Inc | 145.36M |
| NanoString Technologies Inc | 353.41M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 117.45M |
| Shareholders Equity (Quarterly) | 58.58M |
| Debt to Equity Ratio | 1.080 |
| Current Ratio | 3.028 |
| Net Debt Paydown Yield | -1.69% |